Outlook Therapeutics Inc

NASDAQ:OTLK  
2.40
0.00 (0.00%)
4:39:24 PM EDT: $2.40 0.00 (0.00%)
Other Pre-Announcement

Outlook Therapeutics Reports Fiscal Q3 Results

Published: 08/13/2021 12:25 GMT
Outlook Therapeutics Inc (OTLK) - Q3 Loss per Share $0.07.
Qtrly Loss per Share $0.07.
at June 30, 2021, Outlook Therapeutics Had Cash and Cash Equivalents of $19.7 Million.
Cash and Cash Equivalents on Hand Are Sufficient to Fund Planned Operations Through December 2021.